Articles producció científica> Bioquímica i Biotecnologia

Tricarboxylic acid cycle related-metabolites and risk of atrial fibrillation and heart failure

  • Dades identificatives

    Identificador: imarina:9231322
    Autors:
    Bullo, MonicaPapandreou, ChristopherGarcia-Gavilan, JesusRuiz-Canela, MiguelLi, JunGuasch-Ferre, MartaToledo, EstefaniaClish, ClaryCorella, DoloresEstruch, RamonRos, EmilioFito, MontserratLee, Chih-HaoPierce, KerryRazquin, CristinaAros, FernandoSerra-Majem, LluisLiang, LimingMartinez-Gonzalez, Miguel AHu, Frank BSalas-Salvado, Jordi
    Resum:
    Background: Tricarboxylic acid (TCA) cycle deregulation may predispose to cardiovascular diseases, but the role of TCA cycle-related metabolites in the development of atrial fibrillation (AF) and heart failure (HF) remains unexplored. This study sought to investigate the association of TCA cycle-related metabolites with risk of AF and HF. Methods: We used two nested case-control studies within the PREDIMED study. During a mean follow-up for about 10 years, 512 AF and 334 HF incident cases matched by age (±5 years), sex and recruitment center to 616 controls and 433 controls, respectively, were included in this study. Baseline plasma levels of citrate, aconitate, isocitrate, succinate, malate and D/L-2-hydroxyglutarate were measured with liquid chromatography-tandem mass spectrometry. Multivariable conditional logistic regression models were fitted to estimate odds ratios (OR) and 95% confidence intervals (95% CI) for metabolites and the risk of AF or HF. Potential confounders included smoking, family history of premature coronary heart disease, physical activity, alcohol intake, body mass index, intervention groups, dyslipidemia, hypertension, type 2 diabetes and medication use. Results: Comparing extreme quartiles of metabolites, elevated levels of succinate, malate, citrate and D/L-2-hydroxyglutarate were associated with a higher risk of AF [ORQ4 vs. Q1 (95% CI): 1.80 (1.21–2.67), 2.13 (1.45–3.13), 1.87 (1.25–2.81) and 1.95 (1.31–2.90), respectively]. One SD increase in aconitate was directly associated with AF risk [OR (95% CI): 1.16 (1.01–1.34)]. The corresponding ORs (95% CI) for HF comparing extreme quartiles of malate, aconitate, isocitrate and D/L-2-hydroxyglutarate were 2.15 (1.29–3.56), 2.16 (1.25–3.72), 2.63 (1.56–4.44) and 1.82 (1.10–3.04), respectively. The
  • Altres:

    Autor segons l'article: Bullo, Monica; Papandreou, Christopher; Garcia-Gavilan, Jesus; Ruiz-Canela, Miguel; Li, Jun; Guasch-Ferre, Marta; Toledo, Estefania; Clish, Clary; Corella, Dolores; Estruch, Ramon; Ros, Emilio; Fito, Montserrat; Lee, Chih-Hao; Pierce, Kerry; Razquin, Cristina; Aros, Fernando; Serra-Majem, Lluis; Liang, Liming; Martinez-Gonzalez, Miguel A; Hu, Frank B; Salas-Salvado, Jordi
    Departament: Bioquímica i Biotecnologia
    Autor/s de la URV: Bulló Bonet, Mònica / García Gavilán, Jesús Francisco / Salas Salvadó, Jorge
    Paraules clau: Tricarboxylic acid cycle metabolites Succinic acid Risk Predimed Middle aged Malic acid Male Malates Isocitric acid Isocitrates Incidence Hydroxyglutarate Humans Heart failure Glutarates Female Citric acid cycle Citric acid Case-control studies Atrial fibrillation Alpha-ketoglutarate Alpha-hydroxyglutarate Aged Aconitic acid profiles predimed plasma mechanisms hydroxyglutarate heart failure failing heart disease dehydrogenase cardiovascular risk cardiomyopathy biomarkers atrial fibrillation
    Resum: Background: Tricarboxylic acid (TCA) cycle deregulation may predispose to cardiovascular diseases, but the role of TCA cycle-related metabolites in the development of atrial fibrillation (AF) and heart failure (HF) remains unexplored. This study sought to investigate the association of TCA cycle-related metabolites with risk of AF and HF. Methods: We used two nested case-control studies within the PREDIMED study. During a mean follow-up for about 10 years, 512 AF and 334 HF incident cases matched by age (±5 years), sex and recruitment center to 616 controls and 433 controls, respectively, were included in this study. Baseline plasma levels of citrate, aconitate, isocitrate, succinate, malate and D/L-2-hydroxyglutarate were measured with liquid chromatography-tandem mass spectrometry. Multivariable conditional logistic regression models were fitted to estimate odds ratios (OR) and 95% confidence intervals (95% CI) for metabolites and the risk of AF or HF. Potential confounders included smoking, family history of premature coronary heart disease, physical activity, alcohol intake, body mass index, intervention groups, dyslipidemia, hypertension, type 2 diabetes and medication use. Results: Comparing extreme quartiles of metabolites, elevated levels of succinate, malate, citrate and D/L-2-hydroxyglutarate were associated with a higher risk of AF [ORQ4 vs. Q1 (95% CI): 1.80 (1.21–2.67), 2.13 (1.45–3.13), 1.87 (1.25–2.81) and 1.95 (1.31–2.90), respectively]. One SD increase in aconitate was directly associated with AF risk [OR (95% CI): 1.16 (1.01–1.34)]. The corresponding ORs (95% CI) for HF comparing extreme quartiles of malate, aconitate, isocitrate and D/L-2-hydroxyglutarate were 2.15 (1.29–3.56), 2.16 (1.25–3.72), 2.63 (1.56–4.44) and 1.82 (1.10–3.04), respectively. These associations were confirmed in an internal validation, except for aconitate and AF. Conclusion: These findings underscore the potential role of the TCA cycle in the pathogenesis of cardiac outcomes.
    Àrees temàtiques: Saúde coletiva Odontología Nutrição Medicina iii Medicina ii Medicina i Interdisciplinar General medicine Farmacia Engenharias ii Enfermagem Endocrinology, diabetes and metabolism Endocrinology & metabolism Endocrinology Educação física Ciências biológicas iii Ciências biológicas ii Ciências biológicas i Ciência de alimentos Biotecnología Antropologia / arqueologia
    Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
    Adreça de correu electrònic de l'autor: jesusfrancisco.garcia@urv.cat jesusfrancisco.garcia@urv.cat monica.bullo@urv.cat jordi.salas@urv.cat
    Identificador de l'autor: 0000-0002-0218-7046 0000-0003-2700-7459
    Data d'alta del registre: 2024-10-12
    Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
    URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
    Referència a l'article segons font original: Metabolism-Clinical And Experimental. 125 154915-
    Referència de l'ítem segons les normes APA: Bullo, Monica; Papandreou, Christopher; Garcia-Gavilan, Jesus; Ruiz-Canela, Miguel; Li, Jun; Guasch-Ferre, Marta; Toledo, Estefania; Clish, Clary; Cor (2021). Tricarboxylic acid cycle related-metabolites and risk of atrial fibrillation and heart failure. Metabolism-Clinical And Experimental, 125(), 154915-. DOI: 10.1016/j.metabol.2021.154915
    Entitat: Universitat Rovira i Virgili
    Any de publicació de la revista: 2021
    Tipus de publicació: Journal Publications
  • Paraules clau:

    Endocrinology,Endocrinology & Metabolism,Endocrinology, Diabetes and Metabolism
    Tricarboxylic acid cycle metabolites
    Succinic acid
    Risk
    Predimed
    Middle aged
    Malic acid
    Male
    Malates
    Isocitric acid
    Isocitrates
    Incidence
    Hydroxyglutarate
    Humans
    Heart failure
    Glutarates
    Female
    Citric acid cycle
    Citric acid
    Case-control studies
    Atrial fibrillation
    Alpha-ketoglutarate
    Alpha-hydroxyglutarate
    Aged
    Aconitic acid
    profiles
    predimed
    plasma
    mechanisms
    hydroxyglutarate
    heart failure
    failing heart
    disease
    dehydrogenase
    cardiovascular risk
    cardiomyopathy
    biomarkers
    atrial fibrillation
    Saúde coletiva
    Odontología
    Nutrição
    Medicina iii
    Medicina ii
    Medicina i
    Interdisciplinar
    General medicine
    Farmacia
    Engenharias ii
    Enfermagem
    Endocrinology, diabetes and metabolism
    Endocrinology & metabolism
    Endocrinology
    Educação física
    Ciências biológicas iii
    Ciências biológicas ii
    Ciências biológicas i
    Ciência de alimentos
    Biotecnología
    Antropologia / arqueologia
  • Documents:

  • Cerca a google

    Search to google scholar